Filing Details
- Accession Number:
- 0001104659-24-004458
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-17 16:01:40
- Reporting Period:
- 2024-01-12
- Accepted Time:
- 2024-01-17 16:01:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604191 | First Wave Biopharma Inc. | FWBI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559509 | James Sapirstein | C/O First Wave Biopharma, Inc 777 Yamato Road, Suite 502 Boca Raton FL 33431 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-12 | 166 | $4.20 | 39,166 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- Includes unvested RSUs.
Billionaire Hedge Funds
